Navigation

Preconception care

Quality statement

Women of childbearing age with diabetes are regularly informed of the benefits of preconception glycaemic control and of any risks, including medication that may harm an unborn child. Women with diabetes planning a pregnancy are offered preconception care and those not planning a pregnancy are offered advice on contraception.

Quality measure

Structure

a) Evidence of local arrangements to ensure that women of childbearing age with diabetes are regularly informed about the benefits of preconception glycaemic control and of any risks, including medication which may harm an unborn child.

b) Evidence that women with diabetes planning a pregnancy are offered preconception care.

c) Evidence that women with diabetes not planning a pregnancy are offered advice on contraception.

Process

a) Proportion of women of childbearing age with diabetes who are regularly informed about the benefits of preconception glycaemic control and of any risks including medication that may harm an unborn child.

Numerator - the number of women in the denominator informed about preconception glycaemic control and of any risks including medication that may harm an unborn child at their last diabetes consultation.

Denominator - the number of women of childbearing age with diabetes.

b) Proportion of women of childbearing age with diabetes planning a pregnancy who are offered preconception care from an appropriately trained healthcare professional.

Numerator - the number of women in the denominator offered preconception care from an appropriately trained healthcare professional.

Denominator - the number of women of childbearing age with diabetes planning a pregnancy.

c) Proportion of women of childbearing age with diabetes not planning a pregnancy who are offered advice on contraception.

Numerator - the number of women in the denominator offered advice on contraception.

Denominator - the number of women with diabetes not planning a pregnancy.

Description of what the quality statement means for each audience

Service providers ensure local arrangements that provide information to women of childbearing age with diabetes on preconception glycaemic control and any risks including medication that may harm an unborn child, and ensure women with diabetes planning a pregnancy are offered preconception care, and those not planning a pregnancy are offered advice on contraception.

Healthcare professionals ensure women with diabetes of childbearing age are provided with information on preconception glycaemic control and on any risks including medication that may harm an unborn child, and are offered preconception care if they are planning a pregnancy or offered advice on contraception if they are not planning a pregnancy.

Commissioners ensure they commission care pathways that provide preconception advice for women of childbearing age with diabetes, and offer preconception care for women with diabetes planning a pregnancy and advice on contraception for those not planning a pregnancy.

Women of childbearing age who have diabetes are regularly given advice about the benefits of controlling their blood sugar before a pregnancy, and any risks such as medication that might harm an unborn baby. Women with diabetes who are planning a pregnancy are offered care leading up to the pregnancy. Women not planning a pregnancy are offered advice on contraception.

Source clinical guideline references

NICE clinical guideline 63 recommendation 1.1.1.2.

Data source

Structure

a), b) and c) Local data collection. Contained within NICE clinical guideline 87 Audit support organisational criteria, criteria 1-3.

Process

a), b) and c) Local data collection. NICE clinical guideline 87 Audit support clinical criteria, criterion 37.

A pregestational diabetes audit which is currently being piloted and rolled out in 2012 as part of the next phase of the National Diabetes Audit includes the relevant structure and process measures.

Definitions

Medication that may harm an unborn child includes, but is not limited to:

  • angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists
  • statins
  • oral anti-diabetes hypoglycaemic agents with the exception of metformin.

‘Women of childbearing age with diabetes' refers to all women with diabetes (excluding gestational diabetes) who have childbearing potential.

This page was last updated: 09 May 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.